On July 21, 2026, Cardlytics Inc CDLX, an advertising technology company, announced that it will release its Q2 financial results on August 5, 2026, following the U.S. market close. The company has provided a positive growth outlook for Q2, anticipating revenues between $35 million and $40 million.
- GF Valueā¢ verdict: $18.17 vs Current Price $3.79 = 79.1% undervalued
- GF Scoreā¢: 34/100, indicating potential challenges in financial health and growth prospects.
- Insider activity: $130,000 in insider buys over the past three months.
What's Behind the News?
Cardlytics is gearing up for its Q2 earnings release, which is expected to shed light on its financial performance amid a challenging landscape. The company has projected revenues to grow by approximately 9% compared to Q1, with billed amounts expected to increase by around 10%. This growth comes despite the loss of a significant partner, Bank of America, which has impacted revenues and billed amounts in the previous quarter. CEO Amit Gupta has emphasized that 2026 is a year of execution, highlighting the stabilization of the supply side and the active pursuit of growth plans by existing financial partners.
Cardlytics operates as a commerce media platform that enhances the advertising experience for consumers and businesses alike. With a market capitalization of approximately $22 million, the company is situated within the Communication Services sector, specifically in the Media - Diversified industry. Its primary revenue streams are derived from its Cardlytics platform, which operates in both the U.S. and U.K., and its Bridg platform, which focuses on identity resolution and analytics.
Is CDLX Overvalued or Undervalued?
According to GuruFocus, Cardlytics has a GF Valueā¢ of $18.17, suggesting that the stock is currently undervalued by approximately 79.1% when compared to its current price of $3.79. This significant margin of safety indicates that investors may be able to purchase the stock at a price considerably lower than its intrinsic value. However, potential investors should exercise caution, as the GF Valuation label indicates that CDLX may be a "Possible Value Trap," suggesting that while the stock appears undervalued, there could be underlying issues that warrant further investigation.
Currently, Cardlytics does not have a trailing P/E ratio available, which makes it challenging to compare its valuation against historical averages. However, the absence of a P/E ratio could reflect the company's ongoing financial struggles, particularly following the loss of a major partner. For more detailed insights, you can check the GF Valueā¢.
What Does CDLX's GF Scoreā¢ Tell Us?
The GF Scoreā¢ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Scoreā¢ values have been found to generate higher long-term returns (backtested 2006-2021).
| Metric | Rating |
|---|---|
| GF Scoreā¢ | 34 |
| Financial Strength | 2/10 |
| Profitability | 2/10 |
| Growth | 2/10 |
| Valuation | 2/10 |
| Momentum | 1/10 |
Cardlytics' GF Scoreā¢ of 34 out of 100 indicates that the company may face significant challenges in terms of financial strength, profitability, and growth. The low scores in these areas suggest that while there may be potential for value, the company is currently struggling to establish a solid financial foundation. Investors should be cautious and consider these factors when evaluating the stock. For more information, visit the CDLX stock page.
What Are Insiders Doing with CDLX Stock?
In the past three months, insiders have engaged in both buying and selling activities, with a total of $130,000 in insider purchases and $80,310 in sales. This mixed activity may indicate varying levels of confidence among insiders regarding the company's future prospects.
What This Means for Investors
Given the current data, Cardlytics presents a complex picture for investors. While the stock appears significantly undervalued according to GF Valueā¢, the low GF Scoreā¢ and mixed insider activity suggest caution. Investors should weigh the potential for recovery against the company's recent challenges and ongoing financial struggles.
For the complete analysis, visit the CDLX stock page. You can also use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is CDLX's GF Scoreā¢?
CDLX's GF Scoreā¢ is 34 out of 100, indicating potential challenges in financial health and growth prospects.
Is CDLX overvalued or undervalued?
CDLX is currently undervalued by approximately 79.1% based on its GF Valueā¢ of $18.17 compared to its current price of $3.79.
What is CDLX's P/E ratio compared to historical?
CDLX does not have a trailing P/E ratio available, which suggests ongoing financial struggles, particularly following the loss of a major partner.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
